Inventor · disambiguated record
Robert D. Gordon
Also filed as: GORDON ROBERT · GORDON ROBERT D
9 granted patents·2 pending applications·63 citations·filing 1999–2024
87Inventor score
Files withVELOXIS PHARMACEUTICALS AS4JANSSEN PHARMACEUTICA NV3GORDON ROBERT D2VELOXIS PHARMACEUTICALS INC2
Top patents by PatentIndex Score
11 records- 0196US11110081B2Tacrolimus for improved treatment of transplant patientsVELOXIS PHARMACEUTICALS AS·Filed 2020·Granted Sep 7, 2021·4 cites·28 claims
- 0295US8685998B2Tacrolimus for improved treatment of transplant patientsGORDON ROBERT D·Filed 2009·Granted Apr 1, 2014·25 cites·21 claims
- 0395US8664239B2Tacrolimus for improved treatment of transplant patientsGORDON ROBERT D·Filed 2011·Granted Mar 4, 2014·22 cites·12 claims
- 0493US11123331B2Tacrolimus for improved treatment of transplant patientsVELOXIS PHARMACEUTICALS AS·Filed 2020·Granted Sep 21, 2021·2 cites·25 claims
- 0588US10864199B2Tacrolimus for improved treatment of transplant patientsVELOXIS PHARMACEUTICALS AS·Filed 2016·Granted Dec 15, 2020·2 cites·19 claims
- 0674US2025120955A1Tacrolimus for improved treatment of transplant patientsVELOXIS PHARMACEUTICALS INC·Filed 2024·Application pending·0 cites
- 0769US7179890B2Vascular endothelial growth factor-xJANSSEN PHARMACEUTICA NV·Filed 2004·Granted Feb 20, 2007·1 cites·2 claims
- 0867US12083103B2Tacrolimus for improved treatment of transplant patientsVELOXIS PHARMACEUTICALS INC·Filed 2021·Granted Sep 10, 2024·0 cites·20 claims
- 0963US2014179731A1Tacrolimus For Improved Treatment Of Transplant PatientsVELOXIS PHARMACEUTICALS AS·Filed 2013·Application pending·0 cites
- 1053US6783953B1Vascular endothelial growth factor-XJANSSEN PHARMACEUTICA NV·Filed 1999·Granted Aug 31, 2004·7 cites·7 claims
- 1139US7482320B2Modulation of smooth muscle cell proliferationJANSSEN PHARMACEUTICA NV·Filed 2002·Granted Jan 27, 2009·0 cites·2 claims
Join the waitlist — get patent alerts
Get an alert when Robert D. Gordon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →